Phio Pharmaceuticals Corp.
(NASDAQ : PHIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -1.37%72.851.0%$2085.84m
AMGNAmgen, Inc. -0.11%198.271.3%$912.74m
REGNRegeneron Pharmaceuticals, Inc. -0.62%449.522.6%$775.54m
BIIBBiogen, Inc. -2.69%296.751.5%$711.86m
MRNAModerna, Inc. 7.55%30.050.0%$640.21m
VRTXVertex Pharmaceuticals, Inc. -3.23%217.241.9%$526.89m
ILMNIllumina, Inc. -1.96%269.053.5%$482.68m
ALXNAlexion Pharmaceuticals, Inc. -2.47%84.012.0%$265.76m
AAgilent Technologies, Inc. -3.61%71.061.6%$237.61m
EXASEXACT Sciences Corp. -4.91%57.9021.0%$205.46m
INCYIncyte Corp. -5.60%68.962.5%$167.54m
SGENSeattle Genetics, Inc. -5.92%109.276.1%$162.29m
BMRNBioMarin Pharmaceutical, Inc. -3.79%79.514.3%$160.35m
NVAXNovavax, Inc. 2.43%13.05114.7%$149.95m
CODXCo-Diagnostics, Inc. -2.66%9.150.0%$148.50m

Company Profile

Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics that addresses unmet medical needs. Its clinical product candidate includes RXI-109, an RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.